Literature DB >> 17080203

The role of galactosyltransferases in cell surface functions and in the immune system.

Inka Brockhausen1.   

Abstract

The immune system relies on cellular communication and often on the recognition of carbohydrates by mammalian lectins. Galactose (Gal)-containing structures are involved in both the innate and adaptive immune systems. Gal is a ligand for Gal/N-acetylgalactosmine (GalNAc) receptors and galectins, and is part of the scaffold structure that synthesizes oligosaccharide ligands for selectins, siglecs and other lectins of the immune system. Gal residues are added to glycoproteins and glycolipids by members of a large family of galactosyltransferases. The expression of many of these enzymes is regulated by the action of cytokines, and becomes altered in various disease states. Specific galactosyltransferases have been shown to control cell adhesion and leukocyte functions. Antibodies need to be galactosylated for normal function, and undergalactosylated immunoglobulin (Ig) is associated with rheumatoid arthritis, while Gal is lacking in the IgA of patients with IgA nephropathy. Interactions involving Gal play important roles in host defenses; they can also result in serious pathophysiology. Galactosyltransferases represent potential targets for the control of cell growth and apoptosis, inflammation and infections. Copyright (c) 2006 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080203     DOI: 10.1358/dnp.2006.19.7.1021491

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  7 in total

1.  Biochemical characterization of UDP-Gal:GlcNAc-pyrophosphate-lipid β-1,4-Galactosyltransferase WfeD, a new enzyme from Shigella boydii type 14 that catalyzes the second step in O-antigen repeating-unit synthesis.

Authors:  Changchang Xu; Bin Liu; Bo Hu; Yanfang Han; Lu Feng; John S Allingham; Walter A Szarek; Lei Wang; Inka Brockhausen
Journal:  J Bacteriol       Date:  2010-11-05       Impact factor: 3.490

2.  Knockdown of core 1 beta 1, 3-galactosyltransferase prolongs skin allograft survival with induction of galectin-1 secretion and suppression of CD8+ T cells: T synthase knockdown effects on galectin-1 and CD8+ T cells.

Authors:  Hai-Dan Chen; Xia Zhou; Gang Yu; Ying-Lan Zhao; Yushan Ren; Yi-Dan Zhou; Qiao Li; Xiao-Lian Zhang
Journal:  J Clin Immunol       Date:  2012-03-06       Impact factor: 8.317

3.  Bisimidazolium Salt Glycosyltransferase Inhibitors Suppress Hepatocellular Carcinoma Progression In Vitro and In Vivo.

Authors:  Xue Luan; Ming Sun; Xue Zhao; Jingyi Wang; Ye Han; Yin Gao
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-05

Review 4.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

Review 5.  Crossroads between Bacterial and Mammalian Glycosyltransferases.

Authors:  Inka Brockhausen
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

Review 6.  Eukaryotic protein glycosylation: a primer for histochemists and cell biologists.

Authors:  Anthony Corfield
Journal:  Histochem Cell Biol       Date:  2016-12-23       Impact factor: 4.304

7.  Extraction and structural analysis of Angelica sinensis polysaccharide with low molecular weight and its lipid-lowering effect on nonalcoholic fatty liver disease.

Authors:  Ping Ma; Congyong Sun; Wenjing Li; Wenwen Deng; Michael Adu-Frimpong; Jiangnan Yu; Ximing Xu
Journal:  Food Sci Nutr       Date:  2020-05-18       Impact factor: 2.863

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.